Jonathan Wright

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study

Jean van Wyk, Faïza Ajana, Fiona Bisshop et al. · Clinical Infectious Diseases · 2020 · 273 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Linda T. Vahdat, Brian Pruitt, Carol J. Fabian et al. · Journal of Clinical Oncology · 2009 · 245 citations · Full text

Medicine, Oncology, Pharmacology +15

From Light to Rich ERE: Annotation of Entities, Relations, and Events

Zhiyi Song, Ann Bies, Stephanie Strassel et al. · 2015 · 143 citations · Full text

Language Studies, Computer Science, Linguistics +17

Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial

Olayemi Osiyemi, Stéphane De Wit, Faïza Ajana et al. · Clinical Infectious Diseases · 2022 · 137 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD

Sebastian M. Waldstein, Jonathan Wright, James Warburton et al. · Ophthalmology · 2015 · 126 citations · Full text

Medicine, Ophthalmology, Vision Science +17